ENSC
Ensysce Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.68M
P/E Ratio
—
EPS
$-3.11
Beta
0.88
52W High
$2.75
52W Low
$0.23
50-Day MA
$0.45
200-Day MA
$1.27
Dividend Yield
—
Profit Margin
-250.40%
Forward P/E
0.95
PEG Ratio
—
About Ensysce Biosciences Inc
Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | $4.71M |
| Gross Profit (TTM) | $-5.67M |
| EBITDA | $-10.23M |
| Operating Margin | -370.70% |
| Return on Equity | -1149.00% |
| Return on Assets | -218.20% |
| Revenue/Share (TTM) | $1.20 |
| Book Value | $-0.04 |
| Price-to-Book | 0.85 |
| Price-to-Sales (TTM) | 0.99 |
| EV/Revenue | - |
| EV/EBITDA | -0.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -27.20% |
| Shares Outstanding | $14.69M |
| Float | $14.68M |
| % Insiders | 0.07% |
| % Institutions | 3.31% |
Historical Volatility
HV 10-Day
146.13%
HV 20-Day
114.75%
HV 30-Day
111.39%
HV 60-Day
—
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($16.45 target)
More HEALTHCARE Stocks
Data last updated: 5/25/2026